We are live on
!
Find out more
EIM
Essex Investment Management Portfolio holdings
AUM
$632M
1-Year Est. Return
95.36%
This Fund
S&P 500
This Quarter
Est. Return
+16.88%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$820M
AUM Growth
+$14.5M
(+1.8%)
Cap. Flow
-$58.3M
Cap. Flow
% of AUM
-7.11%
Top 10 Holdings %
Top 10 Hldgs %
15.04%
Holding
537
New
56
Increased
73
Reduced
203
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$6.12M |
| 2 |
CRISPR Therapeutics
CRSP
|
+$5.37M |
| 3 |
Sensata Technologies
ST
|
+$5.01M |
| 4 |
DarioHealth
DRIO
|
+$3.05M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$3.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$8.61M |
| 2 |
SPWR
SunPower Corporation Common Stock
SPWR
|
+$6.72M |
| 3 |
VeriSign
VRSN
|
+$5.32M |
| 4 |
BioLife Solutions
BLFS
|
+$4.9M |
| 5 |
Fulgent Genetics
FLGT
|
+$4.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Healthcare | 17.09% |
| 3 | Industrials | 12.67% |
| 4 | Materials | 10.49% |
| 5 | Consumer Discretionary | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Onto Innovation
ONTO
$20.5B
| $2.18M | 0.27% |
33,236
-4,366
| -12% | -$260K |
|
127
Biodesix
BDSX
$263M
| $2.18M | 0.27% |
+5,369
| New | +$2.4M |
|
|
USCR
128
DELISTED
U S Concrete, Inc.
USCR
| $2.16M | 0.26% |
29,492
-3,065
| -9% | -$165K |
|
129
Luxfer Holdings
LXFR
$457M
| $2.14M | 0.26% |
100,514
-10,619
| -10% | -$200K |
|
130
Starbucks
SBUX
$126B
| $2.13M | 0.26% |
19,537
-28,070
| -59% | -$2.95M |
|
131
Five Below
FIVE
$13.6B
| $2.13M | 0.26% |
11,182
-1,380
| -11% | -$260K |
|
132
Ford
F
$55.7B
| $2.11M | 0.26% |
+172,111
| New | +$1.97M |
|
133
General Motors
GM
$76.6B
| $2.08M | 0.25% |
+36,234
| New | +$1.92M |
|
|
XONE
134
DELISTED
The ExOne Company
XONE
| $2.07M | 0.25% |
65,965
-56,755
| -46% | -$1.79M |
|
|
SUP
135
DELISTED
Superior Industries International
SUP
| $2.06M | 0.25% |
+363,526
| New | +$2.08M |
|
|
SPWR
136
DELISTED
SunPower Corporation Common Stock
SPWR
| $2.06M | 0.25% |
61,581
-179,197
| -74% | -$6.72M |
|
|
FFWM
137
DELISTED
First Foundation Inc
FFWM
| $2.04M | 0.25% |
+87,054
| New | +$1.95M |
|
138
Champion Homes
SKY
$5.15B
| $2.02M | 0.25% |
44,733
-5,626
| -11% | -$226K |
|
139
Neuronetics
STIM
$235M
| $2.01M | 0.24% |
162,362
+28,065
| +21% | +$430K |
|
140
e.l.f. Beauty
ELF
$5.49B
| $2M | 0.24% |
74,727
-9,246
| -11% | -$231K |
|
|
SRGA
141
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $2M | 0.24% |
+30,619
| New | +$2.14M |
|
142
Moderna
MRNA
$25.5B
| $1.96M | 0.24% |
15,000
-6,262
| -29% | -$907K |
|
|
AQUA
143
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $1.96M | 0.24% |
74,628
+13,846
| +23% | +$369K |
|
144
Century Communities
CCS
$2.05B
| $1.96M | 0.24% |
32,504
-4,284
| -12% | -$233K |
|
145
Insulet
PODD
$10.1B
| $1.94M | 0.24% |
7,436
-6,759
| -48% | -$1.81M |
|
146
Gilead Sciences
GILD
$170B
| $1.94M | 0.24% |
30,003
-2,163
| -7% | -$139K |
|
147
Ulta Beauty
ULTA
$22.5B
| $1.85M | 0.23% |
5,999
-249
| -4% | -$77.4K |
|
148
Verizon
VZ
$197B
| $1.85M | 0.23% |
31,895
-24
| -0.1% | -$1.35K |
|
149
FedEx
FDX
$78.4B
| $1.84M | 0.22% |
6,466
-4,375
| -40% | -$1.13M |
|
150
Ameresco
AMRC
$1.47B
| $1.82M | 0.22% |
37,441
-3,892
| -9% | -$214K |
|
Similar funds
BI
KCMH
SFM
VIM
AP
TTSTC
WCM
FTC
Essex Investment Management's Q1 2021 Portfolio in Review
As of Q1 2021, Essex Investment Management held 537 positions worth $820M, up 1.8% from $806M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Essex Investment Management withdrew a net $58.3M in Q1 2021, closing 92 positions and reducing 203 holdings. Its most notable exit was VeriSign, an estimated $5.32M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Essex Investment Management opened a new position in CRISPR Therapeutics worth $4.33M.
- Essex Investment Management's largest Q1 2021 buy was CRISPR Therapeutics: 35,540 shares worth $4.33M.
- Essex Investment Management added most to AT&T in Q1 2021, an estimated $6.12M increase.
- Essex Investment Management's biggest Q1 2021 reduction was Teladoc Health, cutting an estimated $8.61M.
- Essex Investment Management fully exited VeriSign in Q1 2021, selling an estimated $5.32M.
- Essex Investment Management's ten largest holdings make up 15% of its $820M portfolio in Q1 2021.
- Essex Investment Management opened 56 new positions and closed 92 in Q1 2021.
- Essex Investment Management's portfolio value rose 1.8% quarter-over-quarter to $820M.
Based on Essex Investment Management's 13F filing for Q1 2021, filed 12 May 2021.